RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Paliperidone Palmitate for the Treatment of Schizophrenia—Selected Posters
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 3
SP 14
OP 14
DO 10.1177/155989770800800310
UL http://mdc.sagepub.com/content/8/3/14.2.abstract
AB Adherence to the use of oral forms of antipsychotic therapy, which usually require daily administration, is a major problem when treating patients with schizophrenia. Poor adherence is common and can lead to recurrence of symptoms and hospitalization. Paliperidone palmitate is a long-acting injectable formulation that may simplify the medication regimen for both patients and caregivers. This article discusses 3 double-blind, placebo-controlled randomized studies in patients with schizophrenia reported the efficacy and safety of 25, 50, or 100 mg equivalent paliperidone palmitate injected IM every 4 weeks.